bonyf Aktie
WKN DE: BONF01 / ISIN: BE6333353298
28.06.2024 17:12:12
|
bonyf NV: bonyf's 2023 financial statements made available
bonyf NV
/ Key word(s): Annual Results
Dissemination of a Financial Wire News, transmitted by EQS Group. |
Language: | English |
Issuer: | bonyf NV |
Doornzelestraat 114 D | |
9000 Gent | |
Belgium | |
Phone: | +41 79 412 42 79 |
E-mail: | president@bonyf.com |
Internet: | www.bonyf.com |
ISIN: | BE6333353298 |
EQS News ID: | 1936093 |
End of Announcement - EQS News Service |
|
1936093 28-Jun-2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu bonyfmehr Nachrichten
30.06.25 |
Annual Results 2024 (EQS Group) | |
03.06.25 |
bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India (EQS Group) | |
15.05.25 |
bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy (EQS Group) | |
08.04.25 |
bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream (EQS Group) | |
13.03.25 |
bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne (EQS Group) | |
18.02.25 |
bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy (EQS Group) | |
30.01.25 |
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne (EQS Group) |
Analysen zu bonyfmehr Analysen
Aktien in diesem Artikel
bonyf | 12,90 | -7,19% |
|